DelveInsight’s Oncology based Reports

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

Business Consultant, DelveInsight's Oncology based Reports, Notizia, Pharma Consultant, The Business Cocktail

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than...

Read More

Metastatic Pancreatic Cancer Market Size: Emerging therapies, Unmet needs and Forecast analysis

Articles, Business Consultant, DelveInsight's Oncology based Reports, Pharma Consultant

Pancreas is a gland which has two components exocrine component and endocrine component.  The exocrine component which is responsible...

Read More

Non-Small Cell Lung Cancer Market: Treatments and Market Forecast

Articles, Business Consultant, DelveInsight's Oncology based Reports, Pharma Consultant

An estimated number of 18.1 million new cancer cases were registered last year, according to A Cancer Journal for Clinicians 2018;0:1‐31....

Read More

Refractory Metastatic Melanoma Market

Articles, Business Consultant, DelveInsight's Oncology based Reports, Pharma Consultant

The cases of Melanoma have been on a hike for the past thirty years making it the fifth most common cancer among people. By the end of the...

Read More

Global Burden of Liver cancer: Is it rising? 

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Oncology based Reports, Pharma Consultant

Liver Cancer incidence is not as high as the incidence of breast or lung cancer. However, rising diagnosis rates reveal another story....

Read More
Close